about
Biology of Saccular Cerebral Aneurysms: A Review of Current Understanding and Future DirectionsAcute Atherosis of the Uterine Spiral Arteries: Clinicopathologic ImplicationsOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisModulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammationRegulation of atherogenesis by chemokines and chemokine receptorsPsoriasis and comorbid diseases: Epidemiology.Lymphocytes and the adventitial immune response in atherosclerosis.Cardiovascular involvement in autoimmune diseases.Inflammation, immunity, and hypertension.IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance.Structural evidence of anti-atherogenic microRNAsInterleukin-1 and acute brain injury.The human condition: an immunological perspective.Selective IgE deficiency and cardiovascular diseases.Placental lesions associated with acute atherosis.PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in AtherosclerosisA novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors.RETRACTED: A histopathological analysis of the epidemiology of coronary atherosclerosis: an autopsy study.Effect of chronic dementia caregiving and major transitions in the caregiving situation on kidney function: a longitudinal study.Biology of intracranial aneurysms: role of inflammation.The kallikrein-kinin system as a regulator of cardiovascular and renal function.Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected menMulticenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patientsMolecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Association of inflammatory gene polymorphisms and conventional risk factors with arterial stiffness by age.Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease.Natural killer T cells and atherosclerosis: form and function meet pathogenesisTumor necrosis factor superfamily molecules in acute coronary syndromes.Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosisInflammation, atherosclerosis, and psoriasis.
P2860
Q26738382-E9A9E49D-9A2B-487F-AC25-90FFC95D3F2CQ26777023-80DD050E-1B81-4DC1-8398-D6BDA748D4CDQ26822962-FD840EF9-FEEB-4D7E-885A-3A2910207E63Q26998660-C993DD0E-041D-4B76-A85C-9A8D00B82F57Q27003124-E24C9945-92EC-441A-8E47-D7A96903B109Q30235889-59B9915E-C6D7-4328-B012-D7F10DAC9941Q30421884-8B8E590B-95C7-4BD9-9239-799FACDE7D72Q34081242-F72B4218-DB92-4B56-BCF1-35845CB60E56Q34528283-1AD6AAA2-F919-4769-8B59-6CD0DB94CB96Q34908689-2F8D2E50-140B-4F7A-A386-DEBF0C472838Q35017677-4B7661CE-D267-4704-99C3-2BA1D85F47A7Q35056860-293E7B91-DDC6-4599-83B8-09DDE48E95ECQ35188878-ECAEC075-D791-4DFD-9509-C5BF6330D551Q35516115-8143E736-DA74-4E9A-9996-BEBA15ABA0D2Q35558666-65CFD4BC-E28F-4A17-925A-D32E70B81FDFQ35649732-17D6BD77-10DA-414D-B2C3-7AAEE7027F3EQ35711283-9EC42EB1-68EF-4530-A823-D7BDBB0A73BFQ35786288-8B2F68C7-7CB5-47FB-AF0B-8EA81679AE9EQ35814468-7FA5D00D-C225-4C4B-B930-6A7721D8C76FQ36062952-27AE9472-D953-4CB2-9AEB-BD79448C44C2Q36211346-697609E3-D517-4396-9732-4194AB306DFAQ36389061-8A4BCCA7-5C61-44E4-A25B-5468671DB46CQ36396054-2F685315-4918-4C80-B0F2-3C8B27411889Q36497196-D04D8F0D-4228-4DC9-944D-ED59A29D46B8Q36497238-893F73EA-BBE8-4CB3-B349-124B8BF2F53EQ36596629-0F23196F-A475-4BD0-B9A1-F9D40E9AA113Q36710876-5166A82F-6127-43F5-8EA4-2E719E4B6D34Q36731084-CE844D0E-033F-402C-8D79-6C49B29D524FQ36824716-B31E76C2-9663-4A6D-A90E-BC05E4FCE8F7Q36848196-9432764B-6D19-40B0-8D63-1EBD3E849191Q37086410-44A91862-3080-4202-8CC3-67ECAEB815BBQ37206902-3920AA61-AB19-4544-8969-2E7678929E5BQ37254899-C70F7F22-D824-460E-AFCF-477503B02C16Q37326035-048E4FAA-A147-4403-B477-F965BD85385EQ37436638-EFB20DC7-CBF3-4998-940F-2556D34ED29BQ37704741-7E93052D-7363-491A-9226-796A79E6D911Q37726701-0997E105-FAC8-4A55-A5FD-175E2DE57EB4Q37805514-C48D158A-8435-4EED-AA08-77B03D7C477BQ37957869-3AE27089-7644-44EA-881A-D5F0FAE3F55DQ37987473-5E18EC50-3981-4A65-9383-F50D65CC79A9
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Innate and adaptive immunity in atherosclerosis.
@ast
Innate and adaptive immunity in atherosclerosis.
@en
type
label
Innate and adaptive immunity in atherosclerosis.
@ast
Innate and adaptive immunity in atherosclerosis.
@en
prefLabel
Innate and adaptive immunity in atherosclerosis.
@ast
Innate and adaptive immunity in atherosclerosis.
@en
P2860
P1476
Innate and adaptive immunity in atherosclerosis.
@en
P2093
Andrew H Lichtman
René R S Packard
P2860
P2888
P356
10.1007/S00281-009-0153-8
P50
P577
2009-05-16T00:00:00Z
P5875
P6179
1052240080